Laboratory Interest Income from 2010 to 2026

LH Stock

USD 268.04 3.08 1.14%

Laboratory's Interest Income is decreasing with slightly volatile movements from year to year. Interest Income is predicted to flatten to about 163.4 M. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals

Interest Income

First Reported

2019-06-30

Previous Quarter

57.1 M

Current Value

60.3 M

Quarterly Volatility

16.8 M

Covid

Interest Hikes

Check Laboratory financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Laboratory's main balance sheet or income statement drivers, such as Interest Expense of 251.5 M, Total Revenue of 15.7 B or Gross Profit of 4.4 B, as well as many indicators such as Price To Sales Ratio of 1.6, Dividend Yield of 0.0138 or PTB Ratio of 3.26. Laboratory financial statements analysis is a perfect complement when working with Laboratory Valuation or Volatility modules.

Build AI portfolio with Laboratory Stock

Check out the analysis of Laboratory Correlation against competitors.

Latest Laboratory's Interest Income Growth Pattern

Below is the plot of the Interest Income of Laboratory of over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Laboratory's Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Laboratory's overall financial position and show how it may be relating to other accounts over time.

Interest Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Interest Income

Timeline

Laboratory Interest Income Regression Statistics

	Arithmetic Mean	217,817,529
	Geometric Mean	214,537,270
	Coefficient Of Variation	17.78
	Mean Deviation	33,207,031
	Median	212,300,000
	Standard Deviation	38,717,797
	Sample Variance	1499.1T
	Range	99.6M
	R-Value	(0.92)
	Mean Square Error	255.3T
	R-Squared	0.84
	Slope	(7,028,544)
	Total Sum of Squares	23985.1T

Laboratory Interest Income History

	2026	163.4 M
	2025	182.4 M
	2024	202.7 M
	2023	172.2 M
	2022	166 M
	2021	175.4 M
	2020	194.2 M

Other Fundumenentals of Laboratory

Net Interest Income

Laboratory Interest Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Debt	Common Stock	Long Term Debt	Property Plant Equipment	Good Will	Treasury Stock	Short Term Investments	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.94	0.95	0.93	0.95	0.98	0.94	0.82	0.18	0.55	0.8	0.95	0.86	-0.7	0.28	0.79	-0.2	0.87	-0.53	0.52	-0.61	0.36	0.6	0.62	0.61	-0.76
Total Stockholder Equity	0.98		0.86	0.99	0.9	0.96	0.93	0.96	0.76	0.17	0.48	0.72	0.95	0.82	-0.65	0.35	0.81	-0.06	0.79	-0.62	0.42	-0.58	0.31	0.62	0.68	0.7	-0.81
Net Debt	0.94	0.86		0.81	0.88	0.82	0.98	0.79	0.86	0.17	0.59	0.87	0.86	0.87	-0.71	0.1	0.69	-0.48	0.93	-0.33	0.64	-0.58	0.39	0.4	0.41	0.32	-0.6
Retained Earnings	0.95	0.99	0.81		0.9	0.94	0.89	0.95	0.7	0.21	0.52	0.66	0.93	0.76	-0.68	0.34	0.76	0.04	0.72	-0.63	0.3	-0.53	0.31	0.64	0.71	0.71	-0.83
Accounts Payable	0.93	0.9	0.88	0.9		0.83	0.92	0.92	0.65	0.37	0.49	0.64	0.96	0.67	-0.62	0.15	0.7	-0.04	0.73	-0.57	0.43	-0.79	0.62	0.65	0.61	0.5	-0.86
Net Receivables	0.95	0.96	0.82	0.94	0.83		0.91	0.94	0.79	0.14	0.49	0.73	0.91	0.84	-0.65	0.47	0.83	-0.08	0.79	-0.58	0.42	-0.53	0.27	0.67	0.64	0.73	-0.75
Total Liab	0.98	0.93	0.98	0.89	0.92	0.91		0.9	0.84	0.19	0.6	0.84	0.92	0.87	-0.73	0.21	0.74	-0.33	0.92	-0.42	0.58	-0.61	0.4	0.56	0.56	0.5	-0.69
Total Current Assets	0.94	0.96	0.79	0.95	0.92	0.94	0.9		0.64	0.24	0.43	0.62	0.96	0.7	-0.57	0.38	0.79	0.11	0.71	-0.66	0.37	-0.68	0.46	0.8	0.78	0.77	-0.87
Intangible Assets	0.82	0.76	0.86	0.7	0.65	0.79	0.84	0.64		0.0	0.57	0.97	0.67	0.99	-0.7	0.21	0.64	-0.56	0.94	-0.21	0.61	-0.36	0.08	0.23	0.26	0.35	-0.39
Short Term Debt	0.18	0.17	0.17	0.21	0.37	0.14	0.19	0.24	0.0		0.27	-0.09	0.3	-0.06	-0.22	-0.06	-0.16	0.27	-0.05	-0.16	-0.07	-0.49	0.63	0.38	0.24	0.03	-0.42
Common Stock	0.55	0.48	0.59	0.52	0.49	0.49	0.6	0.43	0.57	0.27		0.58	0.39	0.55	-0.97	-0.15	0.03	-0.31	0.56	0.24	0.16	-0.11	0.11	0.15	0.14	0.16	-0.22
Long Term Debt	0.8	0.72	0.87	0.66	0.64	0.73	0.84	0.62	0.97	-0.09	0.58		0.64	0.96	-0.68	0.11	0.58	-0.62	0.98	-0.12	0.71	-0.34	0.05	0.21	0.27	0.33	-0.32
Property Plant Equipment	0.95	0.95	0.86	0.93	0.96	0.91	0.92	0.96	0.67	0.3	0.39	0.64		0.72	-0.55	0.31	0.81	0.01	0.73	-0.72	0.43	-0.73	0.56	0.7	0.68	0.59	-0.91
Good Will	0.86	0.82	0.87	0.76	0.67	0.84	0.87	0.7	0.99	-0.06	0.55	0.96	0.72		-0.69	0.26	0.71	-0.51	0.95	-0.29	0.62	-0.35	0.04	0.29	0.33	0.44	-0.44
Treasury Stock	-0.7	-0.65	-0.71	-0.68	-0.62	-0.65	-0.73	-0.57	-0.7	-0.22	-0.97	-0.68	-0.55	-0.69		0.02	-0.25	0.32	-0.68	-0.05	-0.23	0.2	-0.11	-0.21	-0.2	-0.27	0.36
Short Term Investments	0.28	0.35	0.1	0.34	0.15	0.47	0.21	0.38	0.21	-0.06	-0.15	0.11	0.31	0.26	0.02		0.46	0.2	0.13	-0.5	0.02	-0.01	-0.02	0.37	0.34	0.52	-0.31
Current Deferred Revenue	0.79	0.81	0.69	0.76	0.7	0.83	0.74	0.79	0.64	-0.16	0.03	0.58	0.81	0.71	-0.25	0.46		-0.07	0.67	-0.75	0.39	-0.54	0.28	0.57	0.52	0.58	-0.7
Net Tangible Assets	-0.2	-0.06	-0.48	0.04	-0.04	-0.08	-0.33	0.11	-0.56	0.27	-0.31	-0.62	0.01	-0.51	0.32	0.2	-0.07		-0.59	-0.44	-0.6	-0.11	0.21	0.43	0.41	0.41	-0.38
Long Term Debt Total	0.87	0.79	0.93	0.72	0.73	0.79	0.92	0.71	0.94	-0.05	0.56	0.98	0.73	0.95	-0.68	0.13	0.67	-0.59		-0.2	0.69	-0.44	0.15	0.33	0.36	0.38	-0.41
Capital Surpluse	-0.53	-0.62	-0.33	-0.63	-0.57	-0.58	-0.42	-0.66	-0.21	-0.16	0.24	-0.12	-0.72	-0.29	-0.05	-0.5	-0.75	-0.44	-0.2		-0.04	0.5	-0.39	-0.61	-0.61	-0.56	0.85
Deferred Long Term Liab	0.52	0.42	0.64	0.3	0.43	0.42	0.58	0.37	0.61	-0.07	0.16	0.71	0.43	0.62	-0.23	0.02	0.39	-0.6	0.69	-0.04		-0.42	0.14	0.09	0.09	0.1	-0.12
Long Term Investments	-0.61	-0.58	-0.58	-0.53	-0.79	-0.53	-0.61	-0.68	-0.36	-0.49	-0.11	-0.34	-0.73	-0.35	0.2	-0.01	-0.54	-0.11	-0.44	0.5	-0.42		-0.81	-0.69	-0.44	-0.35	0.71
Short Long Term Debt	0.36	0.31	0.39	0.31	0.62	0.27	0.4	0.46	0.08	0.63	0.11	0.05	0.56	0.04	-0.11	-0.02	0.28	0.21	0.15	-0.39	0.14	-0.81		0.56	0.34	0.04	-0.65
Cash And Equivalents	0.6	0.62	0.4	0.64	0.65	0.67	0.56	0.8	0.23	0.38	0.15	0.21	0.7	0.29	-0.21	0.37	0.57	0.43	0.33	-0.61	0.09	-0.69	0.56		0.81	0.78	-0.76
Net Invested Capital	0.62	0.68	0.41	0.71	0.61	0.64	0.56	0.78	0.26	0.24	0.14	0.27	0.68	0.33	-0.2	0.34	0.52	0.41	0.36	-0.61	0.09	-0.44	0.34	0.81		0.83	-0.73
Net Working Capital	0.61	0.7	0.32	0.71	0.5	0.73	0.5	0.77	0.35	0.03	0.16	0.33	0.59	0.44	-0.27	0.52	0.58	0.41	0.38	-0.56	0.1	-0.35	0.04	0.78	0.83		-0.6
Capital Stock	-0.76	-0.81	-0.6	-0.83	-0.86	-0.75	-0.69	-0.87	-0.39	-0.42	-0.22	-0.32	-0.91	-0.44	0.36	-0.31	-0.7	-0.38	-0.41	0.85	-0.12	0.71	-0.65	-0.76	-0.73	-0.6

Click cells to compare fundamentals

About Laboratory Financial Statements

Investors use fundamental indicators, such as Laboratory's Interest Income, to determine how well the company is positioned to perform in the future. Although Laboratory's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

	Last Reported	Projected for Next Year
Interest Income	182.4 M	163.4 M
Net Interest Income	-239.5 M	-251.5 M

Currently Active Assets on Macroaxis

WD	Walker Dunlop
GM	General Motors
GM	General Motors
BAC	Bank of America
S	SentinelOne

How To Invest In Laboratory

Details

Is Laboratory Stock a good investment?

Details

What is Laboratory's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Laboratory Correlation against competitors.

You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Is there potential for Health Care Providers & Services market expansion? Will Laboratory introduce new products? Factors like these will boost the valuation of Laboratory. Expected growth trajectory for Laboratory significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.56

Dividend Share

2.88

Earnings Share

10.19

Revenue Per Share

164.953

Quarterly Revenue Growth

0.086

The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Understanding that Laboratory's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Laboratory represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Laboratory's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Laboratory Interest Income from 2010 to 2026

Latest Laboratory's Interest Income Growth Pattern

Laboratory Interest Income Regression Statistics

Laboratory Interest Income History

Other Fundumenentals of Laboratory

Laboratory Interest Income component correlations

About Laboratory Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY